| pubmed-article:20874771 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:20874771 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:20874771 | lifeskim:mentions | umls-concept:C0020514 | lld:lifeskim |
| pubmed-article:20874771 | lifeskim:mentions | umls-concept:C0486616 | lld:lifeskim |
| pubmed-article:20874771 | lifeskim:mentions | umls-concept:C0205360 | lld:lifeskim |
| pubmed-article:20874771 | lifeskim:mentions | umls-concept:C1171824 | lld:lifeskim |
| pubmed-article:20874771 | lifeskim:mentions | umls-concept:C1517942 | lld:lifeskim |
| pubmed-article:20874771 | pubmed:issue | 6 | lld:pubmed |
| pubmed-article:20874771 | pubmed:dateCreated | 2010-11-16 | lld:pubmed |
| pubmed-article:20874771 | pubmed:abstractText | Macroprolactin, which comprises immunoglobulin G (IgG) or anti-prolactin (PRL) autoantibody-bound PRL, is one of the causes of hyperprolactinaemia. This study evaluated the composition and stability of macroprolactin and determined whether the condition was long lasting. We also investigated whether we could predict the composition of macroprolactin based on the ratio of polyethylene glycol (PEG)-precipitable PRL. | lld:pubmed |
| pubmed-article:20874771 | pubmed:language | eng | lld:pubmed |
| pubmed-article:20874771 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20874771 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:20874771 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20874771 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20874771 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20874771 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20874771 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20874771 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:20874771 | pubmed:month | Dec | lld:pubmed |
| pubmed-article:20874771 | pubmed:issn | 1365-2265 | lld:pubmed |
| pubmed-article:20874771 | pubmed:author | pubmed-author:IshiharaTakas... | lld:pubmed |
| pubmed-article:20874771 | pubmed:author | pubmed-author:HattoriNaokiN | lld:pubmed |
| pubmed-article:20874771 | pubmed:author | pubmed-author:ShimatsuAkira... | lld:pubmed |
| pubmed-article:20874771 | pubmed:author | pubmed-author:SaikiYasuhiko... | lld:pubmed |
| pubmed-article:20874771 | pubmed:copyrightInfo | © 2010 Blackwell Publishing Ltd. | lld:pubmed |
| pubmed-article:20874771 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:20874771 | pubmed:volume | 73 | lld:pubmed |
| pubmed-article:20874771 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:20874771 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:20874771 | pubmed:pagination | 792-7 | lld:pubmed |
| pubmed-article:20874771 | pubmed:meshHeading | pubmed-meshheading:20874771... | lld:pubmed |
| pubmed-article:20874771 | pubmed:meshHeading | pubmed-meshheading:20874771... | lld:pubmed |
| pubmed-article:20874771 | pubmed:meshHeading | pubmed-meshheading:20874771... | lld:pubmed |
| pubmed-article:20874771 | pubmed:meshHeading | pubmed-meshheading:20874771... | lld:pubmed |
| pubmed-article:20874771 | pubmed:meshHeading | pubmed-meshheading:20874771... | lld:pubmed |
| pubmed-article:20874771 | pubmed:meshHeading | pubmed-meshheading:20874771... | lld:pubmed |
| pubmed-article:20874771 | pubmed:meshHeading | pubmed-meshheading:20874771... | lld:pubmed |
| pubmed-article:20874771 | pubmed:meshHeading | pubmed-meshheading:20874771... | lld:pubmed |
| pubmed-article:20874771 | pubmed:meshHeading | pubmed-meshheading:20874771... | lld:pubmed |
| pubmed-article:20874771 | pubmed:meshHeading | pubmed-meshheading:20874771... | lld:pubmed |
| pubmed-article:20874771 | pubmed:year | 2010 | lld:pubmed |
| pubmed-article:20874771 | pubmed:articleTitle | Macroprolactinaemia in patients with hyperprolactinaemia: composition of macroprolactin and stability during long-term follow-up. | lld:pubmed |
| pubmed-article:20874771 | pubmed:affiliation | Department of Pharmaceutical Sciences, Ritsumeikan University, Shiga, Japan. hattorin@fc.ritsumei.ac.jp | lld:pubmed |
| pubmed-article:20874771 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:20874771 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
